【肺癌】《OncoHost》的「PROphet®」平台將支持《Hengenix》進行「SCLC」三期臨床

 【肺癌】《OncoHost》的「PROphet®」平台將支持《Hengenix》在美進行「SCLC」第三期臨床試驗

 文章出處  

 CISION

 

 原文標題  

OncoHost's PROphet® Platform to Support Henlius US-Based Phase III Trial for Patients with Extensive-Stage Small Cell Lung Cancer 

 

 Twitter  

https://twitter.com/aimedadviser/status/1709461017745674617 

 

 文章序號  

4471 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2023 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.